1.1.1.153: sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)
This is an abbreviated version!
For detailed information about sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming), go to the full flat file.
Word Map on EC 1.1.1.153
-
1.1.1.153
-
tetrahydrobiopterin
-
bh4
-
aldo-keto
-
cyclohydrolase
-
aldose
-
neurotransmitter
-
pterins
-
dopa-responsive
-
tetrahydropterins
-
6-pyruvoyl-tetrahydropterin
-
n-acetylserotonin
-
dystonia
-
dihydropteridine
-
dihydroneopterin
-
6-pyruvoyl
-
pteridine
-
neopterin
-
gtpch
-
ptges
-
gtp-cyclohydrolase
-
5-hydroxytryptophan
-
akr1b3
-
6r-5,6,7,8-tetrahydrobiopterin
-
epalrestat
-
hyperphenylalaninaemia
-
segawa
-
2,4-diamino-6-hydroxypyrimidine
-
medicine
- 1.1.1.153
- tetrahydrobiopterin
- bh4
-
aldo-keto
-
cyclohydrolase
- aldose
-
neurotransmitter
- pterins
-
dopa-responsive
- tetrahydropterins
- 6-pyruvoyl-tetrahydropterin
- n-acetylserotonin
- dystonia
- dihydropteridine
- dihydroneopterin
-
6-pyruvoyl
- pteridine
- neopterin
- gtpch
- ptges
-
gtp-cyclohydrolase
- 5-hydroxytryptophan
- akr1b3
- 6r-5,6,7,8-tetrahydrobiopterin
- epalrestat
- hyperphenylalaninaemia
-
segawa
- 2,4-diamino-6-hydroxypyrimidine
- medicine
Reaction
Synonyms
AKR1B1, MDSPI16 protein, MDSPR, reductase, sepiapterin, sepiapterin reductase, SPR, SR
ECTree
Advanced search results
Application
Application on EC 1.1.1.153 - sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
medicine
-
polymorphisms of sepiapterin reductase gene alter promoter activity and may influence risk of bipolar disorder
medicine
high sepiapterin reductase expression is significantly correlated to unfavorable neuroblastoma characteristics like high age at diagnosis, MYCN amplification, and high INSS stage. Sulfasalazine inhibits the growth of neuroblastoma cells in vitro, presumably due to the inhibition of sepiapterin reductase. The combination of sulfasalazine with alpha-difluoromethylornitine produces synergistic antiproliferative effects in vitro
medicine
siRNA-mediated knock-down of sepiapterin reductase expression significantly reduces endogenous ornithine decarboxylase enzyme activity in neuroblastoma cells. In a cohort of 88 human neuroblastoma tumors, high SPR mRNA expression correlates significantly with poor survival prognosis
medicine
the enzyme can regulate chronic pain and is a target for the development of analgesics